Literature DB >> 23287865

Comparison of primary human cytotoxic T-cell and natural killer cell responses reveal similar molecular requirements for lytic granule exocytosis but differences in cytokine production.

Samuel C C Chiang1, Jakob Theorell, Miriam Entesarian, Marie Meeths, Monika Mastafa, Waleed Al-Herz, Per Frisk, Kimberly C Gilmour, Marianne Ifversen, Cecilia Langenskiöld, Maciej Machaczka, Ahmed Naqvi, Jeanette Payne, Antonio Perez-Martinez, Magnus Sabel, Ekrem Unal, Sule Unal, Jacek Winiarski, Magnus Nordenskjöld, Hans-Gustaf Ljunggren, Jan-Inge Henter, Yenan T Bryceson.   

Abstract

Cytotoxic lymphocytes, encompassing cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells, kill pathogen-infected, neoplastic, or certain hematopoietic cells through the release of perforin-containing lytic granules. In the present study, we first performed probability-state modeling of differentiation and lytic granule markers on CD8(+) T cells to enable the comparison of bona fide CTLs with NK cells. Analysis identified CD57(bright) expression as a reliable phenotype of granule marker-containing CTLs. We then compared CD3(+)CD8(+)CD57(bright) CTLs with NK cells. Healthy adult peripheral blood CD3(+)CD8(+)CD57(bright) CTLs expressed more granzyme B but less perforin than CD3(-)CD56(dim) NK cells. On stimulation, such CTLs degranulated more readily than other T-cell subsets, but had a propensity to degranulate that was similar to NK cells. Remarkably, the CTLs produced cytokines more rapidly and with greater frequency than NK cells. In patients with biallelic mutations in UNC13D, STX11, or STXBP2 associated with familial hemophagocytic lymphohistiocytosis, CTL and NK cell degranulation were similarly impaired. Therefore, cytotoxic lymphocyte subsets have similar requirements for Munc13-4, syntaxin-11, and Munc18-2 in lytic granule exocytosis. The present results provide a detailed comparison of human CD3(+)CD8(+)CD57(bright) CTLs and NK cells and suggest that analysis of CD57(bright) CTL function may prove useful in the diagnosis of primary immunodeficiencies including familial hemophagocytic lymphohistiocytosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23287865     DOI: 10.1182/blood-2012-07-442558

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  55 in total

1.  Hemophagocytic syndrome with atypical presentation in an adolescent.

Authors:  Marta Valente Pinto; Isabel Esteves; Yenan Bryceson; Anabela Ferrão
Journal:  BMJ Case Rep       Date:  2013-09-11

2.  Application of an improved flow cytometry-based NK cell activity assay in adult hemophagocytic lymphohistiocytosis.

Authors:  Jia Zhang; Yini Wang; Lin Wu; Jingshi Wang; Ran Tang; Shuo Li; Jianhang Chen; Zhuo Gao; Ruijun Pei; Zhao Wang
Journal:  Int J Hematol       Date:  2017-02-09       Impact factor: 2.490

3.  Hemophagocytic lymphohistiocytosis caused by dominant-negative mutations in STXBP2 that inhibit SNARE-mediated membrane fusion.

Authors:  Waldo A Spessott; Maria L Sanmillan; Margaret E McCormick; Nishant Patel; Joyce Villanueva; Kejian Zhang; Kim E Nichols; Claudio G Giraudo
Journal:  Blood       Date:  2015-01-06       Impact factor: 22.113

4.  A critical role for alpha-synuclein in development and function of T lymphocytes.

Authors:  Afshin Shameli; Wenbin Xiao; Yan Zheng; Susan Shyu; John Sumodi; Howard J Meyerson; Clifford V Harding; Robert W Maitta
Journal:  Immunobiology       Date:  2015-10-20       Impact factor: 3.144

5.  Ultrastructural changes in peripheral blood leukocytes in α-synuclein knockout mice.

Authors:  Hammad Tashkandi; Afshin Shameli; Clifford V Harding; Robert W Maitta
Journal:  Blood Cells Mol Dis       Date:  2018-09-01       Impact factor: 3.039

6.  Autoimmunity, hypogammaglobulinemia, lymphoproliferation, and mycobacterial disease in patients with activating mutations in STAT3.

Authors:  Emma M Haapaniemi; Meri Kaustio; Hanna L M Rajala; Arjan J van Adrichem; Leena Kainulainen; Virpi Glumoff; Rainer Doffinger; Heikki Kuusanmäki; Tarja Heiskanen-Kosma; Luca Trotta; Samuel Chiang; Petri Kulmala; Samuli Eldfors; Riku Katainen; Sanna Siitonen; Marja-Liisa Karjalainen-Lindsberg; Panu E Kovanen; Timo Otonkoski; Kimmo Porkka; Kaarina Heiskanen; Arno Hänninen; Yenan T Bryceson; Raija Uusitalo-Seppälä; Janna Saarela; Mikko Seppänen; Satu Mustjoki; Juha Kere
Journal:  Blood       Date:  2014-10-27       Impact factor: 22.113

7.  A CD57+ CTL Degranulation Assay Effectively Identifies Familial Hemophagocytic Lymphohistiocytosis Type 3 Patients.

Authors:  Masayuki Hori; Takahiro Yasumi; Saeko Shimodera; Hirofumi Shibata; Eitaro Hiejima; Hirotsugu Oda; Kazushi Izawa; Tomoki Kawai; Masataka Ishimura; Naoko Nakano; Ryutaro Shirakawa; Ryuta Nishikomori; Hidetoshi Takada; Satoshi Morita; Hisanori Horiuchi; Osamu Ohara; Eiichi Ishii; Toshio Heike
Journal:  J Clin Immunol       Date:  2016-11-28       Impact factor: 8.317

Review 8.  Molecular regulation of the plasma membrane-proximal cellular steps involved in NK cell cytolytic function.

Authors:  Prasad V Phatarpekar; Daniel D Billadeau
Journal:  J Cell Sci       Date:  2020-02-21       Impact factor: 5.285

Review 9.  Bispecific T-Cell Redirection versus Chimeric Antigen Receptor (CAR)-T Cells as Approaches to Kill Cancer Cells.

Authors:  William R Strohl; Michael Naso
Journal:  Antibodies (Basel)       Date:  2019-07-03

10.  Late stages of hematopoiesis and B cell lymphopoiesis are regulated by α-synuclein, a key player in Parkinson's disease.

Authors:  Wenbin Xiao; Afshin Shameli; Clifford V Harding; Howard J Meyerson; Robert W Maitta
Journal:  Immunobiology       Date:  2014-07-22       Impact factor: 3.144

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.